peroxisome proliferator-activated receptor ␥ (McIntyre et al., 2003) . Given the complexity of cellular responses to LPA signaling and the potential role of LPA receptor subtypes in various cancers (Mills and Moolenaar, 2003) , it is important to understand the mechanisms that regulate the activity of individual LPA receptors.
Upon agonist stimulation, most GPCRs are rapidly internalized into cells through a variety of different endocytic pathways. This facilitates either receptor downregulation or receptor resensitization (Marchese et al., 2003) . Agonist stimulation usually leads to the rapid phosphorylation of serine/threonine residues located within cytoplasmically exposed regions of GPCRs (Ferguson et al., 1995) . This subsequently induces the binding of ␤-arrestin proteins, which results in signal attenuation and often targets the GPCR to clathrin-coated pits for endocytosis (Lefkowitz and Shenoy, 2005) . Internalized GPCRs transit through the endosomal system and are either sorted to lysosomes for degradation or become dephosphorylated by membrane-associated phosphatases and are recycled back to the plasma membrane (Ferguson, 2001) . In addition to clathrin-mediated endocytosis, many GPCRs utilize a variety of clathrin-independent Lysophosphatidic acid (LPA) stimulates heterotrimeric G protein signaling by activating three closely related receptors, termed LPA 1 , LPA 2 and LPA 3 . Here we show that in addition to promoting LPA 1 signaling, membrane cholesterol is essential for the association of LPA 1 with ␤ ␤-arrestin, which leads to signal attenuation and clathrindependent endocytosis of LPA 1 . Reduction of clathrin heavy chain expression, using small interfering RNAs, inhibited LPA 1 endocytosis. LPA 1 endocytosis was also inhibited in ␤ ␤-arrestin 1 and 2-null mouse embryo fibroblasts (␤ ␤-arrestin 1/2 KO MEFs), but was restored upon re-expression of wild-type ␤ ␤-arrestin 2. ␤ ␤-arrestin attenuates LPA signaling as LPA 1 -dependent phosphoinositide hydrolysis was significantly elevated in ␤ ␤-arrestin 1/2 KO MEFs and was reduced to wild-type levels upon re-expression of wild-type ␤ ␤-arrestin. Interestingly, extraction of membrane cholesterol with methyl-␤ ␤-cyclodextrin inhibited LPA 1 signaling, ␤ ␤-arrestin membrane recruitment and LPA 1 endocytosis. Cholesterol repletion restored all of these functions. However, neither the stimulation of phosphoinositide hydrolysis by the M 1 acetylcholine receptor nor its endocytosis was affected by cholesterol extraction. LPA treatment increased the detergent resistance of LPA 1 and this was inhibited by cholesterol extraction, suggesting that LPA 1 localizes to detergent-resistant membranes upon ligand stimulation. These data indicate that although LPA 1 is internalized by clathrin-and ␤ ␤-arrestin dependent endocytosis, membrane cholesterol is critical for LPA 1 signaling, membrane recruitment of ␤ ␤-arrestins and LPA 1 endocytosis.
internalization mechanisms including cholesterol-dependent pathways such as caveolae (Chini and Parenti, 2004) . Also, ␤-arrestins are not universally required for GPCR endocytosis as shown for the thrombin receptor, PAR1, whose association with ␤-arrestins is required for signal attenuation but not for its endocytosis (Paing et al., 2002) . Thus, the mechanisms that regulate both signal attenuation and receptor endocytosis can vary from one GPCR to another.
We have previously shown that LPA 1 is probably internalized by clathrin-dependent endocytosis as dominantnegative mutants of dynamin 2 (K44A) and Rab 5 (S34N), which regulate clathrin-dependent trafficking, strongly inhibited LPA 1 endocytosis (Murph et al., 2003) . However, a recent study showed that LPA stimulation of the phosphoinositide 3-kinase (PI3-K)/Akt pathway was dependent upon membrane cholesterol (Peres et al., 2003) suggesting a positive role for cholesterol-rich plasma membrane microdomains in LPA signaling. As cholesterolenriched microdomains, such as caveolae, can also mediate receptor endocytosis, it is not clear what the relationship is between LPA signaling from cholesterol-rich microdomains and the endocytosis of LPA receptors. To address this question and to gain a better understanding about the regulation of LPA receptors, we investigated the role of membrane cholesterol, ␤-arrestins and clathrin in the signaling and endocytosis of the ubiquitously-expressed LPA 1 receptor.
Materials and Methods

Antibodies and reagents
Lysophosphatidic acid (1-oleoyl-2-hydroxy-sn-glycero-3-phosphate; LPA) was purchased from Avanti Polar Lipids (Alabaster, AL). Isoproterenol and cytochalasin D was obtained from Sigma Chemical Co. (St Louis, MO) and carbachol from Fluka Chemika-Biochemika. FLAG-tagged LPA 1 receptors were detected with mouse anti-FLAG antibodies (Sigma, St Louis, MO); HA-tagged ␤ 2 AR and HA-tagged M 1 muscarinic acetylcholine receptor (mAChR) were detected with mouse anti-HA antibodies (Covance, Berkeley, CA). Alexa 488-labeled transferrin (Alexa 488-Tfn), Alexa 594-and Alexa 488-conjugated goat anti-mouse were purchased from Molecular Probes (Eugene, OR). Monoclonal antibodies to clathrin heavy chain and monoclonal anti-actin antibodies were purchased from BD Transduction labs (San Jose, CA) and Santa Cruz Biotechnology (Santa Cruz, CA), respectively. Mouse anti-AP2 antibodies were purchased from Affinity Bioreagents (Golden, CO). FITC-labeled anti-CD59 was obtained from Chemicon (Temecula, CA). Methyl-␤-cyclodextrin and water-soluble cholesterol complexes were purchased from Sigma. myo-[ 3 H]inositol was purchased from American Radiolabeled Chemicals (St Louis, MO).
Cell culture and DNA transfection HeLa cells stably expressing the LPA 1 receptor (termed LPA 1 /HeLa cells), native HeLa cells, wild-type (WT) MEF and ␤-arrestin 1/2 KO MEF cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, 100 g/ml streptomycin (Media Tech, Herndon, VA) and 1 mM sodium pyruvate (Biosource International, Camarillo, CA) at 37°C with 5% CO 2 . Cells were grown on glass coverslips (for immunolocalization) and transfected in six-well dishes, or were grown in 24-well dishes (for myo-[ 3 H]inositol labeling) using Lipofectin or Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to manufacturer's directions. Plasmids encoding HA-tagged ␤ 2 AR, ␤-arrestin 1-GFP, ␤-arrestin-2-GFP, HA-tagged M 1 mAchR were transiently transfected at 1.0 g/well (in six-well plates) and have been previously described (Paing et al., 2002; Scott et al., 2002) .
siRNA-mediated reduction of clathrin siRNA oligonucleotides to clathrin were purchased from Dharmacon (Lafayette, CO) and have been described previously (Motley et al., 2003) . LPA 1 /HeLa cells were transiently transfected with 300 pmol (10 cm dish) or 100 pmol (24-well plate) of siRNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). The transfection medium was replaced with complete medium (without penicillin/streptomycin) 5 hours later and the cells were incubated for 16 hours. The cells were transfected a second time as above and the medium was then replaced with serum-free medium (SFM) and incubated for an additional 16 hours before experimentation.
Indirect immunofluorescence Cells were treated as described in the figure legends, 24-48 hours after transfection. Cells were then fixed in 2% formaldehyde in phosphatebuffered saline (PBS) for 10 minutes and rinsed with 10% fetal bovine serum (FBS) containing 0.02% azide in PBS (PBS-serum). Fixed cells were incubated with primary antibodies diluted in PBS-serum containing 0.2% saponin for 45 minutes and then washed (three times, 5 minutes each) with PBS-serum. The cells were then incubated in fluorescently labeled secondary antibodies diluted in PBS-serum containing 0.2% saponin for 45 minutes, washed three times with PBS-serum, washed once with PBS and mounted on glass slides as previously described (Murph et al., 2003) .
For Alexa 594-Tfn and FITC-labeled anti-CD59 internalization, LPA 1 /HeLa cells were briefly rinsed three times with 0.5% bovine serum albumin (BSA) in SFM and incubated in the same medium for 30 minutes at 37°C. The cells were then incubated with Alexa 594-conjugated human transferrin (50 g/ml) or FITC-conjugated anti-CD59 (1 g/ml) for 30 minutes at 37°C in the presence or absence of 10 M LPA. Antibodies bound to the cell surface were removed by rinsing the cells with 0.5% acetic acid, 0.5 M NaCl, pH 3.0 solution (for Alexa 488-Tfn) or 100 mM glycine, 20 mM magnesium acetate, 50 mM KCl, pH 2.2 (for FITC anti-CD59) (Naslavsky et al., 2004) . Cells were rinsed in complete medium, fixed and processed for fluorescence microscopy. For assessing uptake in the presence of methyl-␤-cyclodextrin (5 mM) or nystatin (50 g/ml), cells were pretreated with DMEM supplemented with 0.5% BSA, with or without drugs, for 60 minutes prior to antibody and/or LPA addition. All images were acquired using an Olympus BX40 epifluorescence microscope equipped with a 60ϫ Planapo lens and photomicrographs were prepared using an Olympus MagnaFire SP digital camera (Olympus America, Melville, NY). Images were processed with Adobe Photoshop 6.0 software.
Quantification of LPA 1 colocalization with internalized AlexaTfn Stably-transfected LPA 1 /HeLa cells or transiently-transfected HeLa cells expressing M 1 mAChRs were grown on glass coverslips and treated with M␤CD and/or water-soluble cholesterol as described in the figure legends. The cells were then incubated with 50 g/ml Alexa 594-Tfn for 30 minutes in the presence or absence of 10 M LPA or 1 mM carbachol, respectively. The cells were rinsed with a mild acid wash as described above, fixed with 2% formaldehyde in PBS and processed for immunofluorescence localization of LPA 1 using M1 mouse anti-FLAG IgG or M 1 mAChR using mouse anti-HA IgG followed by Cy2 secondary antibodies. The extent of LPA 1 or M 1 colocalization with internalized Alexa 594-Tfn was determined by quantifying the extent of pixel colocalization of GPCR staining with Alexa 594-Tfn fluorescence using Metamorph Imaging software (Universal Imaging, West Chester, PA) as described (Murph et al., 2003; Volpicelli et al., 2001 ). The background was subtracted from LPA 1 receptor signaling and trafficking unprocessed images and the percentage of GPCR pixels that overlapped with Alexa-Tfn pixels was measured. The data is presented as the mean±s.e.m. of measurements from 20 cells per sample from a representative experiment that was performed three independent times with similar results.
Immunoblotting
Following 72 hours of siRNA treatment, cells were solubilized by addition of lysis buffer (1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 0.15 M NaCl, 0.01 M sodium phosphate pH 7.2, 2 mM EDTA, 50 mM NaF, 0.2 M sodium orthovanadate, 0.02% azide, 100 g/ml leupeptin and 0.1 mM PMSF) and incubated on ice for 60 minutes. The samples (12 g protein per lane) were then separated by 10% SDS-PAGE and transferred to nitrocellulose. Clathrin heavy chain was detected using mouse anti-clathrin antibodies and actin was detected using monoclonal anti-actin antibodies. The binding of primary antibodies was detected by using an enhanced chemifluorescence detection kit (Amersham Biosciences, Piscataway, NJ).
Phosphoinositide hydrolysis LPA 1 /HeLa cells or mouse embryo fibroblasts derived from wild-type or ␤-arrestin 1/2 null mice were plated at a density of 4.0ϫ10 4 cells/well into 24-well plates and transfected with plasmids encoding wild-type LPA 1 or M1 mAChRs alone or in combination with plasmids encoding wild-type ␤-arrestin 2 using Lipofectamine 2000. Transient transfection of plasmids encoding M 1 mAChRs was performed by using Lipofectin reagent. At 24 hours post-transfection, cells were labeled overnight with myo-[ 3 H]inositol in inositol-and serum-free medium, treated as described in the figure legends and then processed for analysis of phosphoinositide hydrolysis by anion exchange chromatography as described (Paing et al., 2002) .
Triton X-100 extraction of cells LPA 1 /HeLa cells were plated onto glass coverslips in 35 mm dishes at a density of 0.2ϫ10 6 cells per plate. After allowing cells to attach for 24 hours, the medium was changed to serum-free medium and the cells were incubated overnight (~16 hours). The following day, the cells were treated as described in the figure legends and subsequently incubated with ice-cold 1% Triton X-100 in PBS on ice for 3 minutes prior to fixation with ice-cold 2% formaldehyde in PBS. LPA 1 or was localized using indirect immunofluorescence microscopy. To monitor the fate of surface LPA 1 , LPA 1 /HeLa cells were incubated on ice with mouse anti-FLAG antibodies for 30 minutes after LPA treatment to label only surface LPA 1 . These cells were then extracted with 1% Triton X-100, fixed and processed for immunofluorescence localization as described above. Relative receptor expression was quantified by measuring receptor pixel intensity using MetaMorph imaging software and was normalized to DNA content, labeled with Hoescht dye.
Whole-cell ELISA quantification of surface LPA 1 LPA 1 /HeLa cells were plated in 24-well dishes (Falcon) at a density of 0.4ϫ10 5 cells per well and grown overnight. Cells were then transiently transfected with no siRNA or with 100 pmol/well of clathrin-specific siRNA (Motley et al., 2003) using Lipofectamine 2000 reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). After 24 hours, the cells were again transfected with 100 pmol/well of clathrin-specific siRNA or no siRNA. 24 hours later, the cells were incubated in the presence or absence of 10 M LPA for 45 minutes and fixed in 2% formaldehyde in phosphate-buffered saline (PBS) for 10 minutes and rinsed with 10% fetal bovine serum (FBS), containing 0.02% azide, in PBS (PBS-serum). Fixed cells were incubated with mouse anti-M1 FLAG primary antibody diluted in PBS-serum (250 l/well) for 1 hour and then washed (three times, 5 minutes each) with PBS-serum. The cells were then incubated with horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody (Pierce Biotechnology, Rockford, IL) diluted in PBS-serum (250 l/well) for 1 hour, washed three times with PBS-serum and washed three times with PBS. The cells were then incubated for 1 hour at 37°C with ABTS (2,2Ј-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt) (Pierce Biotechnology). A 200 l aliquot was then removed from each well, transferred to a 96-well plate and the absorbance read at 405 nm (corrected for blank). Internalization is expressed as the percent difference in surface LPA 1 between unstimulated cells and agonist-stimulated cells. The data are the mean±s.e.m. of six replicates/siRNA sample combined from two independent experiments.
Cholesterol measurements
HeLa cells, stably expressing FLAG-tagged LPA 1 , were seeded in sixwell plates at a density of 0.5ϫ10 6 cells per well, allowed to attach overnight and then incubated with serum-free DMEM for 24 hours prior to treatment. The cells were treated for 60 minutes, as described in the figure legend, rinsed twice with ice-cold PBS (pH 7.4) and then solubilized in ice-cold PBS (pH 7.4) containing 1% Triton X-100 and protease inhibitor cocktail (2 mM AEBSF, 1 mM EDTA, 130 M bestatin, 14 M E-64, 1 M leupeptin and 0.3 M aprotinin). Total cellular cholesterol was quantified using an Amplex Red Cholesterol Assay Kit (Molecular Probes; Eugene, OR), as indicated by the manufacturer. Briefly, cholesterol esters in the cell extracts are hydrolyzed by cholesterol esterase into cholesterol, which is then oxidized by cholesterol oxidase to yield H 2 O 2 , which is detected using 10-acetyl-3,7-dihydroxyphenoxazine (Amplex Red). In the presence of horseradish peroxidase (HRP), Amplex Red reacts with H 2 O 2 to produce fluorescent resorufin. Fluorescence was measured with a fluorescence microplate reader using excitation at 560 nm and fluorescence detection at 590 nm and total cholesterol was calculated from a standard curve using purified cholesterol. Cellular cholesterol was normalized to total protein concentration, which was quantified by BCA Protein Assay (Pierce Biotechnology).
Statistical analysis
The data is expressed as the mean±s.e.m. from the indicated number of independent experiments performed in triplicate. Differences were analyzed by two-factor ANOVA followed by a Tukey's statistical significance test.
Results
LPA 1 is internalized by clathrin-mediated endocytosis
Our previous work suggested that LPA 1 was internalized by clathrin-dependent endocytosis based on the inhibitory effects of mutant dynamin 2 K44A and Rab 5 S34N (Murph et al., 2003) . However dynamin K44A can also inhibit endocytosis from cholesterol-rich caveolae (Damke et al., 1994; Henley et al., 1998; Murph et al., 2003) . To directly test whether LPA 1 used a clathrin-dependent pathway, we determined the effects of reducing the cellular abundance of the clathrin heavy chain, using small interfering RNAs (siRNAs), on the endocytosis of LPA 1 . Fig. 1A shows the distribution of FLAG-tagged LPA 1 in stably transfected HeLa cells (LPA 1 /HeLa cells). In untreated cells, LPA 1 is localized predominantly at the plasma membrane and to a lesser extent, at the Golgi complex, which probably represents newly synthesized LPA 1 en route to the plasma membrane. Treatment with 10 M LPA results in a redistribution of LPA 1 to numerous punctate structures, which we have previously shown to colocalize with transferrinreceptor-positive endosomes (Murph et al., 2003) .
To investigate the role of clathrin in LPA 1 endocytosis, we adapted a double-transfection procedure that was previously described (Motley et al., 2003) to knock down clathrin heavy chain amounts in HeLa cells to near undetectable levels. Using this procedure, we observed a 73% reduction in the abundance of clathrin relative to mock-transfected siControl cells (Fig. 1B) in LPA 1 /HeLa cells. Treatment of cells with clathrin siRNA did not alter the abundance of actin. Endocytosis of LPA 1 was quantified by using a whole-cell ELISA, which measures the agonist-induced loss of cell surface LPA 1 (Kim and Benovic, 2002; Paing et al., 2002) . In siControl cells, 10 M LPA induced LPA 1 internalization (~30%) and this was strongly inhibited in siClathrin cells (~2%) (Fig. 1C) . In siClathrin cells, both the agonist-stimulated internalization of ␤ 2 -adrenergic receptors (␤ 2 ARs) (data not shown), which are known to use clathrin-dependent mechanisms (von Zastrow and Kobilka, 1992) and the constitutive endocytosis of Alexa transferrin was strongly inhibited (Fig. 1D) .
As a negative control, we examined the effects of clathrin knockdown on the endocytosis of anti-CD59 antibodies bound to endogenous CD59, which is internalized via cholesterolrich, detergent-resistant membranes and then merges with a clathrin-independent trafficking pathway that is regulated by the Arf6 GTPase as shown by Naslavsky et al. (Naslavsky et al., 2004) . LPA 1 /HeLa cells were transfected either with or without clathrin siRNAs and then incubated with FITC-labeled mouse anti-CD59 antibodies along with Alexa 594-Tfn for 30 minutes. The cells were acid-stripped to remove surface-bound anti-CD59 antibodies and Alexa 594-Tfn. In cells transfected with clathrin siRNAs, FITC-labeled anti-CD59 antibodies localized to pleomorphic tubulovesicular structures (Fig. 1D , Anti-CD59) similar to those described (Naslavsky et al., 2004) . As expected, these same siRNA-treated cells did not internalize Alexa 594-Tfn (Fig. 1D , Alexa 594-Tfn). Taken together, these results indicate that LPA 1 is internalized by clathrin-mediated endocytosis.
␤-arrestins are critical for LPA 1 signal attenuation and receptor endocytosis Clathrin-mediated endocytosis of many GPCRs is also dependent upon their association with the multi-functional ␤-arrestins (Ferguson et al., 1996; Marchese et al., 2003) . ␤-arrestin binding is initiated through the agonist-induced phosphorylation of cytoplasmic serine/threonine residues in the GPCR by G protein receptor kinases (GRKs) such as GRK2 (Pitcher et al., 1998) . ␤-arrestin binding promotes both receptor desensitization, by preventing receptor-G protein coupling and clathrin-dependent endocytosis of the receptor. To determine whether ␤-arrestins are required for LPA 1 endocytosis, we compared agonist-stimulated internalization of LPA 1 and ␤ 2 AR in mouse embryo fibroblasts (MEFs) derived from either wild-type or ␤-arrestin 1 and 2 null mice (Kohout et al., 2001) (Fig. 2) . Wild-type MEFs were transiently transfected with plasmids encoding either LPA 1 or ␤ 2 ARs and then incubated in the presence or absence of agonist. In the absence of agonist treatment, both receptors were primarily localized to the plasma membrane in a diffuse pattern ( Fig. 2A,  untreated) . Upon agonist treatment for 30 minutes, both LPA 1 and ␤ 2 ARs redistributed to small punctate endosomal Journal of Cell Science 118 (22) structures dispersed throughout the cell. The labeling of these structures was not observed in non-permeabilized cells, thus indicating that they were internal endosomal structures (Fig.  1A, non-permeabilized) . In contrast to wild-type MEFs, agonist treatment of ␤-arrestin 1/2 KO MEFs expressing either LPA 1 or ␤ 2 ARs did not lead to their endocytosis (Fig. 2B,  +agonist) . Expression of wild-type ␤-arrestin-2-GFP in the knockout cells restored agonist-induced endocytosis of both LPA 1 (Fig. 3A, 30 minutes) and ␤ 2 ARs (data not shown), thus indicating that ␤-arrestins were required for the endocytosis of LPA 1 as well as ␤ 2 ARs.
Previous studies have shown that agonist stimulation of different GPCRs leads to the translocation of cytosolic ␤-arrestin proteins to the plasma membrane (Barak et al., 1997) . For some GPCRs such as ␤ 2 ARs, this association with ␤-arrestins is transient and is not observed following receptor endocytosis, whereas other GPCRs, such as angiotensin AT1a receptors and vasopressin receptors, maintain a stable association with ␤-arrestins even on endosomes after endocytosis . To determine whether LPA 1 formed a transient or stable association with ␤-arrestins, we examined the distribution of LPA 1 and ␤-arrestin-2-GFP after 0, 2 and 30 minutes of LPA treatment (10 M) (Fig. 3A) . In untreated cells, LPA 1 localized to the plasma membrane and ␤-arrestin-2-GFP localized in a diffuse cytoplasmic pattern (Fig. 3A, Untreated) . After 2 minutes of LPA treatment, LPA 1 localized to small punctate structures, which partially colocalized with ␤-arrestin-2-GFP (Fig. 3A, inset, arrows) . However, many punctate structures contained LPA 1 but did not contain ␤-arrestin-2-GFP, particularly in the larger and more pleotropic structures. Following 30 minutes of LPA treatment, LPA 1 localized to heterogeneously sized endosomal structures, but ␤-arrestin-2-GFP returned to the diffuse cytoplasmic pattern observed in untreated cells (Fig. 3A, 30 minutes) . This suggested that ␤-arrestins dissociate from LPA 1 receptors at or near the cell surface and do not form a stable association with ␤-arrestin proteins, as defined by Oakley et al. (Oakley et al., 1997) . Taken together, these data indicate that ␤-arrestins are critical for the endocytosis of LPA 1 and that LPA 1 only transiently associates with ␤-arrestins at the cell surface.
As mentioned above, ␤-arrestin binding to activated GPCRs leads to signal attenuation (Lefkowitz and Whalen, 2004) . We next investigated whether ␤-arrestins were important for the desensitization of LPA 1 . We examined the ability of LPA 1 receptors, which activate G i , G q and G 12/13 signaling pathways (Fukushima et al., 1998) , to promote phosphoinositide (PI) hydrolysis, via G q stimulation of phospholipase C, in the wild type and ␤-arrestin 1/2 KO MEFs (Fig. 3B) . LPA 1 -transfected wild type and ␤-arrestin 1/2 KO MEFs were labeled with [ 3 H]inositol and the accumulation of inositol phosphates was determined in untreated cells and cells treated with 10 M LPA for 60 minutes at 37°C. LPA treatment increased the accumulation of [ 3 H]inositol phosphates in wild-type MEFs bỹ 2.5-fold. However, stimulation of LPA 1 -transfected ␤-arrestin 1/2 KO MEFs led to a 4.3-fold increase in inositol phosphate accumulation, suggesting that ␤-arrestins are important for attenuation of LPA signaling. To further test this, we determined the effects of re-expression of wild-type ␤-arrestin 2 on inositol phosphate accumulation in LPA 1 -transfected ␤-arrestin 1/2 KO MEFs (Fig. 3B) . Co-transfection of wild-type ␤-arrestin 2 and LPA 1 in the ␤-arrestin 1/2 KO MEFs reduced the magnitude of LPA-induced inositol phosphate accumulation to 3.1-fold, which was similar to that observed in LPA 1 -transfected WT MEFs (2.5-fold). Taken together, these observations strongly support the notion that ␤-arrestin association with LPA 1 receptors is important for signal attenuation and for clathrin-mediated receptor internalization.
Membrane cholesterol is required for LPA 1 signaling and receptor endocytosis Having established that the agonist-induced endocytosis of LPA 1 was mediated by a ␤-arrestin-and clathrin-dependent pathway, we next investigated the role of membrane cholesterol in LPA 1 signaling and trafficking. As mentioned, membrane cholesterol has been shown to be important for LPA stimulation of PI3-kinase/Akt signaling (Peres et al., 2003) . To address this question, we first examined the effects of cholesterol extraction with methyl-␤-cyclodextrin (M␤CD) and the effects of cholesterol disruption with the cholesterolbinding drug, nystatin, on LPA stimulation of phosphoinositide hydrolysis, which is stimulated by Gq signaling. As a first step, we measured the effects of these cholesterol-perturbing drugs and the effects of water-soluble cholesterol:M␤CD complexes on the cellular abundance of cholesterol in LPA 1 /HeLa cells by using a quantitative cholesterol measurement assay (see Materials and Methods) ( Table 1) . Control LPA 1 /HeLa cells contained 17.10±0.13 g cholesterol/mg protein and treatment with 5 mM M␤CD for 1 hour reduced cellular cholesterol by 62% to 6.52±0.05 g cholesterol/mg protein. Addition of 10 mM cholesterol, as a water-soluble M␤CD complex, for 1 hour after M␤CD extraction, increased cellular cholesterol levels to approximately twice that observed in control cells (34.2±0.78 g cholesterol/mg protein). In contrast, treatment of LPA 1 /HeLa cells with 50 g/ml nystatin for 1 hour slightly elevated the amount of cellular cholesterol (20.8±1.5 g cholesterol/mg protein) and addition of water-soluble cholesterol to nystatin-treated cells increased cellular cholesterol amounts by approximately 2.5-fold relative to control LPA 1 /HeLa cells (42.9±1.3 g cholesterol/mg protein). This is consistent with the notion that nystatin merely binds sterols but does not extract them from cells.
We next examined the effects of these cholesterol-perturbing drugs on LPA 1 stimulation of phosphoinositide hydrolysis, Journal of Cell Science 118 (22) Fig. 3 . Re-expression of wild-type ␤-arrestin 2 GFP in ␤-arrestin knockout MEFs restores LPA 1 signal attenuation and receptor endocytosis. (A) ␤-arrestin 1/2 double knockout MEFs were transiently transfected with plasmids encoding LPA 1 and wild-type ␤-arrestin-2-GFP. Cells were then incubated with 10 M LPA for 0, 2, or 30 minutes prior to fixation and indirect immunofluorescence. The inset shows a magnified image of the boxed region and the arrows indicate punctate structures that co-label for both LPA 1 and ␤-arrestin-2-GFP. Note that the recruitment of ␤-arrestin2-GFP to these punctate structures is transient, observable after 2 minutes of LPA treatment but not after 30 minutes of LPA treatment. (B) MEFs derived from wild type (WT) or ␤-arrestin 1/2 null (␤Arr 1/2KO) mice were transfected with plasmid encoding wild-type LPA 1 receptors; ␤-arrestin 1/2 null MEFs were also co-transfected with plasmids encoding LPA 1 and wild-type ␤-arrestin 2 (␤Arr 1/2KO + LPA 1 + WT ␤Arr2). Cells were then labeled with [ 3 H]myo-inositol overnight in serum-free medium and incubated for 1 hour in the absence (Untreated) or presence of 10 M LPA prior to analysis of phosphoinositide hydrolysis, as described in Materials and Methods. The radioactivity recovered in the different samples was normalized to total cellular protein and the data are presented as the mean±s.e.m. of triplicate measurements from a representative experiment that was repeated three times. **P<0.01, comparison of LPA-stimulated phosphoinositide hydrolysis in ␤-arrestin 1/2 KO MEFs to that observed in WT MEFs. Bar, 10 m. *Stably transfected LPA 1 /HeLa cells were left untreated (Control) or were incubated with 5 mM M␤CD for 1 hour, 50 g/ml nystatin for 1 hour, 5 mM M␤CD for 1 hour followed by 10 mM cholesterol/M␤CD for 1 hour or 50 g/ml nystatin for 1 hour followed by 10 mM cholesterol/M␤CD for 1 hour. Cells were then solubilized and total cellular cholesterol content was quantified as described in the Materials and Methods. The amount of cellular cholesterol was normalized to total cellular protein and is presented as the mean±s.e.m. of triplicate measurements from a representative experiment that was repeated twice. which is promoted by Gq stimulation of phospholipase C. LPA stimulation of native HeLa cells (Fig. 4A , HeLa) resulted in a small 1.9-fold increase in accumulation of [ 3 H]inositol phosphates, whereas stimulation of LPA 1 /HeLa cells resulted in a large increase in PI hydrolysis (~14-fold) (Fig. 4A, lane  1) . Treatment of LPA 1 /HeLa cells with 5 mM M␤CD reduced LPA stimulated PI hydrolysis to 3.9-fold (72% inhibition) (Fig.  4A, lane 2) . Treatment of LPA 1 /HeLa cells with 50 g/ml nystatin did not significantly affect agonist-dependent PI hydrolysis (Fig. 4A, lane 4) . Addition of water-soluble cholesterol:M␤CD complexes, which contained 10 mM cholesterol, to M␤CD-treated or nystatin-treated cells greatly increased the extent of basal accumulation of labeled inositol phosphates (Fig. 4A, lanes 3 and 5) . Addition of water-soluble cholesterol led to a greater increase in the basal level of inositol phosphate accumulation as compared to that observed in LPAstimulated samples, which consequently decreased the fold induction of PI hydrolysis by LPA. This could be due to enhanced G q signaling that is independent of LPA 1 receptors. These results suggested that the presence of membrane cholesterol was important for LPA 1 stimulation of PI hydrolysis.
As a control, we examined the effects of M␤CD on the stimulation of PI hydrolysis by an unrelated G q -coupled receptor, the M 1 muscarinic acetylcholine receptor (M 1 mAChR). For these experiments, HeLa cells were transiently transfected with plasmids encoding either wild-type LPA 1 or M 1 mAChRs. Whereas 5 mM M␤CD inhibited LPA 1 -mediated PI hydrolysis (Fig. 4B, compare lanes 3 and 4) as expected, it did not significantly reduce the extent of PI hydrolysis in response to agonist stimulation (1 mM carbachol) of M 1 mAChR-expressing cells (Fig. 4B, compare lanes 5 and 6) . Immunofluorescence microscopy indicated that the transfection efficiencies of the LPA 1 and M 1 mAChR plasmids were comparable and were approximately 40% (data not shown). These results indicated that the reduction of LPA 1 -mediated PI hydrolysis by M␤CD was not due to inhibition of either G␣ q or phospholipase C activities, but rather was due to a specific inhibition of LPA 1 function. Taken together, these results suggest that the presence of plasma membrane cholesterol is critical for LPA 1 -dependent signaling to phospholipase C (Fig. 4) .
Next, we investigated whether membrane cholesterol was also important for LPA 1 endocytosis. We compared the effects of M␤CD on the agonist-induced endocytosis of LPA 1 and M 1 mAChRs, which are also internalized by clathrin-and ␤-arrestin-dependent mechanisms (Vogler et al., 1999) . Stablytransfected LPA 1 /HeLa cells or transiently-transfected HeLa cells expressing M 1 mAChRs were pre-incubated in the presence or absence of 5 mM M␤CD for 1 hour. These cells were then incubated with the respective agonists and Alexa 594-Tfn for 30 minutes. In untreated cells, LPA 1 and M 1 mAChRs localized to the plasma membrane, whereas Alexa 594-Tfn labeled pleomorphic endosomal structures (Fig. 5A,  untreated) . Agonist stimulation induced the endocytosis of (lanes 3 and 4) , or M 1 mAChRs (lanes 5 and 6). The cells were incubated in the absence (-) or presence (+) of 5 mM M␤CD for 1 hour prior to a subsequent 1 hour incubation with agonist (10 M LPA or 1 mM carbachol). After solubilization, the radioactivelylabeled inositol phosphates were isolated as described. The radioactivity recovered in the different samples was normalized to total cellular protein and the data are presented as the mean±s.e.m. of triplicate measurements from a representative experiment that was repeated three times. **P<0.01, comparison of LPA-stimulated phosphoinositide hydrolysis in M␤CD-treated LPA 1 -transfected HeLa cells to that observed in non-M␤CD-treated cells.
both receptors into endosomal structures that colocalized with internalized Alexa 594-Tfn (Fig. 5A, +agonist) . To quantify GPCR endocytosis, we measured the extent of GPCR (either LPA 1 or M 1 ) colocalization with the internalized Alexa 594-Tfn using Metamorph image analysis (Murph et al., 2003; Volpicelli et al., 2001) . In control cells, treatment with 10 M LPA increased LPA 1 and Alexa 594-Tfn colocalization by 3.3-fold relative to untreated cells (Fig. 5B, Control) . Preincubation with 5 mM M␤CD reduced this agonist-induced colocalization by more than 50% (Fig. 5B , compare black bars in control cells to cells treated with 5 mM M␤CD). Addition of 10 mM water-soluble cholesterol restored LPA 1 and Alexa 594-Tfn colocalization to near control levels (Fig. 5B , M␤CD + cholesterol). In contrast to LPA 1 , agonist treatment (1 mM carbachol, 30 minutes) stimulated a twofold increase in M 1 mAChR colocalization with Alexa 594-Tfn, which was not inhibited by M␤CD (Fig. 5C ). These data suggested that plasma membrane cholesterol is important for both LPA 1 endocytosis and LPA 1 signaling.
LPA 1 localizes to detergent-resistant membrane microdomains upon agonist stimulation Although the data above indicates that membrane cholesterol is essential for LPA 1 endocytosis, the data in Fig. 1-3 indicate that LPA 1 is internalized by clathrin-and ␤-arrestin-dependent mechanisms, which are distinct from cholesterol-dependent endocytic pathways (Nichols, 2003) . To further investigate this apparent difference, we examined whether LPA 1 localized to detergent-resistant membrane domains, which are enriched in both cholesterol and glycosphingolipids (Razani et al., 2002) . We examined the effects of LPA stimulation on the resistance of LPA 1 to extraction with Triton X-100. LPA 1 /HeLa cells were incubated with 10 M LPA for different times before extraction with ice-cold 1% Triton X-100 and indirect immunofluorescence (Fig. 6A) . LPA 1 staining in unstimulated cells was greatly reduced following Triton X-100 extraction (Fig. 6A, 0 minute) . In contrast, the cell-associated LPA 1 staining, which remained after detergent extraction, was increased with time of agonist stimulation (Fig. 6A) . We quantified the detergent-resistant LPA 1 staining associated with the cells by measuring the pixel intensity of LPA 1 -specific fluorescence using MetaMorph image analysis (see materials and methods) and normalizing this value to DNA content as assessed by Hoescht dye labeling (Fig. 6B ). This analysis showed that detergent extraction of unstimulated cells reduced the level of cell-associated LPA 1 staining to 5% of that observed in untreated and non-extracted cells. Cell-associated LPA 1 staining progressively increased with time of LPA treatment such that after 30 minutes of LPA stimulation approximately 38% of LPA 1 immunoreactive staining remained after detergent extraction, relative to control cells (Fig. 6B, solid circles) . Extraction of membrane cholesterol with 5 mM M␤CD prior to LPA stimulation blocked the LPA-induced increase in detergent resistance of LPA 1 (Fig. 6B, open triangles) . As detergent resistance of proteins can also be increased by their association with the actin cytoskeleton, we examined the effects of inhibiting actin polymerization with cytochalasin D (5 M) on Journal of Cell Science 118 (22) the detergent resistance of LPA 1 (Fig. 6B, open squares) . We observed no noticeable difference between the detergent resistance of LPA 1 in cells pre-treated with cytochalasin D and untreated cells, after brief exposure to LPA (i.e. 0 to 8 minutes). A slight delay in the rate of increase of LPA 1 detergent resistance was observed between 10 and 20 minutes of LPA treatment in cells that were pre-treated with cytochalasin D, but the extent of detergent resistance was the same in both untreated and cytochalasin D-treated cells after 30 minutes of LPA stimulation. These data indicate that LPA treatment promotes the association of LPA 1 with detergent resistant membranes and that this process is inhibited by cholesterol extraction.
Given that LPA treatment for 30 minutes promotes the endocytosis of LPA 1 into transferrin receptor + endosomes, it is likely that some of the detergent resistant LPA 1 receptors observed after longer LPA treatment reside in endosomes. Studies have shown that transferrin receptor + endosomes are enriched in cholesterol (Hao et al., 2002) . To investigate the effects of agonist stimulation on the detergent resistance of surface LPA 1 receptors, we labeled surface LPA 1 with mouse anti-FLAG antibodies on ice prior to detergent extraction (Fig.  6C,D) . The LPA 1 expressed in LPA 1 /HeLa cells contains an Nterminal FLAG epitope tag that is accessible to the extracellular medium. In the absence of detergent, mouse anti-FLAG antibodies labeled only the cell surface in control cells (Fig. 6C, Control) . Triton X-100 extraction removed most of the surface-bound antibody (only 15% of control, un-extracted cells remained) (Fig. 6C,D, 0 minute) . The detergent resistance of surface LPA 1 increased with time of agonist treatment up to 45% of control levels after 6 minutes and then declined after 15 minutes and 30 minutes of LPA treatment (Fig. 6C,D) . These results suggest that the LPA 1 receptor associates with detergent-resistant membranes following agonist stimulation, both at the cell surface and following endocytosis in cholesterol-rich endosomes.
Membrane cholesterol is required for the plasma membrane recruitment of cytosolic ␤-arrestins by activated LPA 1 As ␤-arrestins are required for the clathrin-mediated endocytosis of LPA 1 , we examined whether membrane cholesterol was important for the association of ␤-arrestins with LPA 1 or with ␤ 2 AR, as a control. Preliminary experiments showed that, in HeLa cells that were transiently transfected with plasmid encoding either LPA 1 or ␤ 2 ARs along with ␤-arrestin -2-GFP, both LPA 1 and ␤ 2 ARs transiently recruited cytosolic ␤-arrestin-2-GFP to punctate plasma membrane structures after 2 minutes of agonist stimulation (Fig. 8A,B , Control). Double-labeling experiments showed that ␤-arrestin-2-GFP extensively colocalized with the plasma membrane clathrin adaptor, AP2 (Fig. 7) , suggesting that brief LPA stimulation led to the recruitment of ␤-arrestin-2-GFP to cell surface clathrin-coated pits. After 30 minutes of agonist stimulation, both LPA 1 and ␤ 2 ARs localized to endosomal structures, but ␤-arrestin 2 GFP returned to a cytosolic distribution (data not shown). This is consistent with published reports showing that ␤ 2 ARs transiently associate with ␤-arrestins .
We next examined the effects of cholesterol extraction on the surface recruitment of ␤-arrestin-2-GFP by LPA 1 and ␤ 2 AR after 2 minutes of agonist stimulation (Fig. 8) . ␤-arrestin-2-GFP localized in a diffuse cytoplasmic pattern in unstimulated cells and both LPA 1 and ␤ 2 AR were localized to the plasma membrane (data not shown). After 2 minutes of LPA treatment, ␤-arrestin-2-GFP colocalized with LPA 1 in punctate spots at the cell surface (Fig. 8A , Control, left panels), which also colocalized with AP2 (see Fig. 7 ). Similarly, after 2 minutes of isoproterenol treatment of ␤ 2 AR-expressing cells, ␤-arrestin-2-GFP localized to punctate spots at the cell surface (Fig. 8B , Control, right panels). Pre-incubation with 5 mM M␤CD for 60 minutes completely inhibited the recruitment of ␤-arrestin-2-GFP to the cell surface by LPA 1 and ␤-arrestin-2-GFP remained in a diffuse cytosolic distribution (Fig. 8A, M␤CD , see inset). Addition of 10 mM water-soluble cholesterol restored the ability of LPA 1 to recruit ␤-arrestin-2-GFP to the cell surface in M␤CD-treated cells (Fig. 8A, M␤CD-cholesterol ). In contrast, incubation with M␤CD did not inhibit ␤-arrestin-2-GFP recruitment to punctate surface spots by ␤ 2 ARs (Fig. 8B, M␤CD, see inset) . Addition of water-soluble cholesterol did not alter the surface recruitment of ␤-arrestin 2-GFP by ␤ 2 ARs (Fig. 8B, M␤CD-cholesterol) .
To quantify these effects, we determined the percentage of cells that showed ␤-arrestin recruitment to the plasma membrane after 2 minutes of agonist stimulation of either LPA 1 or ␤ 2 AR (Fig. 8C) . In control cells and in cholesterol repleted cells (i.e. M␤CD-cholesterol), ␤-arrestin-2-GFP was recruited to the cell surface in ~80% of cells expressing either LPA 1 or ␤ 2 AR. Only 4% of LPA 1 -expressing cells showed surface recruitment of ␤-arrestin-2-GFP in M␤CD-treated cells. In contrast, approximately 50% of ␤ 2 AR-expressing cells exhibited surface recruitment of ␤-arrestin-2-GFP. Taken together, these results indicate that LPA 1 is much more dependent upon plasma membrane cholesterol for the recruitment of ␤-arrestin than ␤ 2 ARs. This also provides a possible link between membrane cholesterol and clathrindependent endocytosis of LPA 1 as ␤-arrestin is critical for endocytosis of LPA 1 .
Discussion
All members of the GPCR superfamily share the ability to rapidly respond to agonist stimulation and then to undergo desensitization (Lefkowitz and Shenoy, 2005) . Many of these GPCRs are also rapidly internalized into cells via one of several distinct endocytic pathways. However, the mechanisms that regulate GPCR desensitization and determine the specific endocytic pathway used for internalization vary from receptor Journal of Cell Science 118 (22) to receptor. In this study, we found that LPA 1 receptors are internalized by a clathrin-and ␤-arrestin-dependent pathway, but that they also require plasma membrane cholesterol for receptor signaling and for their subsequent clathrin-dependent endocytosis. Our results indicate that the key requirement of membrane cholesterol for LPA 1 endocytosis is for the association of LPA 1 with ␤-arrestin, which promotes both signal attenuation and clathrin-dependent endocytosis of the receptor.
Caveolae and other detergent-resistant membrane domains are cholesterol-and glycosphinoglipid-rich, are sites of active signal transduction and have been implicated in the activation of heterotrimeric G proteins, Ras signaling and eNOS signaling (Razani et al., 2002) . Several lines of evidence suggest that LPA 1 Rs associate with cholesterol-rich, detergent-resistant membranes and that this is important for LPA 1 -dependent signaling. First, cholesterol extraction with M␤CD strongly inhibited LPA 1 induction of phosphoinositide hydrolysis, via G␣ q -mediated stimulation of phospholipase C (Fig. 4) . G␣ q has been shown to be enriched in caveolae (Huang et al., 1997; Oh and Schnitzer, 2001 ), which supports the notion that LPA 1 stimulates PI hydrolysis by associating with G␣ q in detergentresistant membranes. Re-addition of cholesterol to M␤CD-treated cells increased both the basal and LPA-stimulated levels of PI hydrolysis (Fig. 4A) . The fact that M␤CD extraction did not affect PI hydrolysis by the M 1 mAChR suggests that cholesterol depletion does not impair either G␣ q or phospholipase C activity per se, but that LPA 1 stimulation of PI hydrolysis is particularly sensitive to cholesterol depletion (Fig.  4C) . Two possible explanations for the difference between LPA 1 and M 1 mAChRs are that either LPA 1 exclusively couples to G␣ q that is localized to detergent-resistant membrane domains or that membrane cholesterol is required for the physical association of LPA 1 with G␣ q . Second, we found that LPA stimulation enhanced the resistance of both surface and total LPA 1 to extraction with TX-100 detergent (Fig. 6 ). Resistance to detergent extraction is a common property of proteins that are associated with caveolae and other cholesterol-rich membrane regions (Razani et al., 2002) . The detergentresistance of surface LPA 1 increased during the first 6 minutes of LPA treatment and then declined. This is consistent with a transient association of LPA 1 with detergent-resistant microdomains prior to ␤-arrestin-and clathrin-dependent endocytosis. Disruption of the actin cytoskeleton with 5 M cytochalasin D did not alter the agonist-induced detergent resistance of LPA 1 suggesting that the increased detergent resistance of LPA 1 was not due to its association with the actin cytoskeleton. However, cholesterol extraction completely prevented the agonist-induced detergent resistance of LPA 1 , which is consistent with the notion that LPA 1 associates with cholesterol-rich membrane microdomains.
Interestingly, total detergent-resistant LPA 1 staining increased with time of LPA treatment even after longer periods of agonist stimulation (Fig. 6B, 30 minutes) . We have previously shown that about 35-40% of surface LPA 1 receptors are internalized into transferrin receptor + endosomes after 30 minutes of LPA treatment (Murph et al., 2003) . We hypothesize that some of the detergent-resistant LPA 1 staining observed after longer LPA treatment resides in transferrin receptor + endosomes, which are known to be enriched in cholesterol (Hao et al., 2002) . Finally, a recent study showed that LPA stimulation of phosphoinositide 3-kinase and the downstream effector kinase, Akt, was inhibited by M␤CD treatment in Vero cells (Peres et al., 2003) . Collectively, these data suggest that LPA 1 association with cholesterol-rich plasma membrane regions is critical for LPA-induced signaling through G␣ q . Given that a pool of G␣ q is present in cholesterol-rich caveolae, we hypothesize that the localization of LPA 1 to detergentresistant membranes is important for their association with the pool of G␣ q that is localized to these domains.
In support of a role for cholesterol in LPA 1 endocytosis, we found that cholesterol extraction inhibited LPA 1 association with ␤-arrestin and the subsequent clathrin-dependent endocytosis of the receptor. Many different GPCRs interact with ␤-arrestins, which is important for the proper regulation of receptor function (Lefkowitz and Whalen, 2004) . Phosphorylation of specific serine/threonine residues in either the cytoplasmic tail or the third intracellular loop, by G protein receptor kinases, leads to the recruitment of ␤-arrestin proteins, which in turn block G protein/receptor coupling (desensitization) and also promote clathrin-dependent endocytosis (Ferguson et al., 1996; Ferguson et al., 1995) . Our data show that wild-type LPA 1 receptors transiently recruit ␤-arrestin-2-GFP to discrete AP2 + structures at the cell surface, in an agonist-stimulated fashion (Fig. 3) , but do not colocalize on endosomes with ␤-arrestin-2-GFP (Figs 3 and 8) . ␤-arrestins promote clathrin-dependent endocytosis of GPCRs by localizing receptors to clathrin coated pits through an interaction of ␤-arrestins with both clathrin heavy chain and the 2 subunit of the AP-2 clathrin adaptor complex (Goodman et al., 1996; Laporte et al., 1999) . Using MEFs derived from ␤-arrestin 1 and 2 double-knockout mice, we showed that both signal attenuation and endocytosis of LPA 1 is dependent upon ␤-arrestin (Figs 2 and 3) . Using an RNA interference approach to reduce the cellular abundance of clathrin heavy chain, we showed that knockdown of clathrin inhibited the internalization of LPA 1 , transferrin receptors, but not the internalization of the GPI-anchored protein, CD59, which localize to cholesterolrich membrane regions (Fig. 1) . Taken together, these data indicate that LPA 1 receptors are internalized by ␤-arrestin-and clathrin-dependent endocytosis.
The most significant finding of these studies was that cholesterol extraction inhibited ␤-arrestin recruitment to the plasma membrane by LPA 1 and the subsequent endocytosis of these receptors (Figs 5 and 8) and that re-addition of cholesterol to M␤CD treated cells restored both of these functions. As ␤-arrestin binding to LPA 1 precedes receptor endocytosis, we hypothesize that cholesterol is required for the association of LPA 1 with ␤-arrestins and that it is the lack of ␤-arrestin binding that leads to the inhibition of LPA 1 endocytosis. This is a novel and previously unappreciated role for membrane cholesterol in the recruitment of ␤-arrestins. We speculate that other GPCRs that localize to caveolae may also associate with ␤-arrestin in a cholesterol-dependent manner. ␤ 2 ARs localize to caveolae in cardiomyocytes in the absence of agonist but move out of caveolae and into clathrin-coated pits upon ligand binding (Ostrom et al., 2001; Rybin et al., 2000) . As ␤ 2 AR endocytosis requires ␤-arrestin binding, it is probable that ␤-arrestin also binds to these receptors in caveolae. Whether the association of ␤-arrestin with ␤ 2 ARs in cardiomyocytes is cholesteroldependent remains to be determined.
In contrast to LPA 1 , cholesterol extraction did not inhibit the endocytosis of M 1 mAChRs (Fig. 5) , which also follow a ␤-arrestin-and clathrin-dependent pathway (Vogler et al., 1999) nor did cholesterol extraction inhibit the association of ␤ 2 ARs with ␤-arrestins. This suggests that the cholesterol dependence of ␤-arrestin recruitment is a unique property of LPA 1 . Cholesterol may be important either for the direct recruitment and binding of ␤-arrestins to LPA 1 Rs or for the recruitment of kinases such as GRKs that phosphorylate agonist-stimulated LPA 1 . Indeed, GRK4 and GRK6 are palmitoylated, which is required for their membrane association (Premont et al., 1996; Stoffel et al., 1994) , and palmitoylation has been shown to target many proteins to cholesterol-rich membranes including SNARES (Salaun et al., 2005) , flotillins (Neumann-Giesen et al., 2004) and RGS16 (Hiol et al., 2003) . Recent work has shown that both LPA stimulation and activation of protein kinase C with phorbol esters promotes LPA 1 phosphorylation (Avendano-Vazquez et al., 2005) .
Are there physiological contexts where changes in cellular cholesterol modulate LPA signaling? One intriguing example may be prostate cancer cells, whose growth is potently stimulated by LPA. Cholesterol is elevated in these cells and contributes to their enhanced growth (Heemers et al., 2001; Mills and Moolenaar, 2003; Zhuang et al., 2002) , perhaps by augmenting LPA signaling. Future studies should provide the answer to this and other questions about this novel process.
